syphili
sexual
transmit
diseas
std
caus
spirochet
bacterium
treponema
pallidum
tp
subspeci
pallidum
despit
exist
inexpens
effect
antibiot
treatment
regimen
syphili
continu
major
public
health
problem
accord
recent
world
health
organ
estim
approxim
million
new
syphili
case
occur
yearli
throughout
globe
although
vener
syphili
reemerg
develop
countri
individu
acquir
diseas
resid
less
affluent
region
world
cali
colombia
latin
american
studi
site
yearli
incid
vener
syphili
last
decad
estim
around
case
per
ge
aristizab
citi
cali
health
depart
std
divis
person
commun
approxim
significantli
higher
western
europ
unit
state
base
high
rate
well
document
gestat
congenit
syphili
rate
citi
like
underestim
true
preval
vener
syphili
cali
inde
recent
studi
conduct
collabor
sexual
activ
year
old
men
women
differ
socioeconom
depriv
cali
district
comuna
serum
rpr
valu
studi
men
sex
men
msm
femal
commerci
sex
worker
transsexu
cali
also
found
seroposit
syphili
strategi
control
sexual
transmiss
tp
thu
urgent
need
colombia
harm
consequ
syphili
infect
pregnant
women
unborn
children
also
strong
associ
vener
syphili
increas
risk
acquir
transmit
human
immunodefici
viru
hiv
begin
curb
spread
vener
syphili
import
health
care
provid
becom
adept
distinguish
typic
atyp
sign
symptom
associ
earli
syphilit
infect
unlik
invas
bacteri
infecti
diseas
vener
syphili
multistag
ill
clinic
manifest
reflect
propens
tp
dissemin
system
induc
persist
chronic
inflamm
divers
tissu
organ
system
infect
begin
bacterium
come
contact
skin
mucos
membran
multipli
local
sever
day
simultan
dissemin
blood
vessel
lymphat
appear
painless
ulcer
commonli
known
chancr
typic
appear
week
initi
contact
spirochet
time
organ
dissemin
primari
site
infect
variou
organ
system
throughout
dermi
set
stage
classic
known
secondari
syphili
stage
diseas
princip
focu
current
studi
character
overt
system
clinic
featur
includ
varieti
dermal
manifest
well
system
sign
symptom
typic
appear
within
week
initi
infect
despit
evolv
natur
adapt
immun
respons
includ
presenc
opson
antibodi
may
take
week
case
month
host
gain
upper
hand
invad
pathogen
ultim
give
rise
asymptomat
stage
known
latent
syphili
earli
latenc
first
year
postinfect
patient
may
experi
recurr
spirochetemia
well
clinic
relaps
indic
host
inabl
fulli
erad
control
bacterium
due
cours
patient
enter
late
latenc
sever
year
later
develop
recrudesc
form
diseas
collect
refer
tertiari
syphili
bacterium
dissemin
primari
secondari
site
infect
persist
human
host
extend
period
time
despit
vigor
cellular
humor
adapt
immun
respons
evok
remain
unresolv
greater
progress
toward
deciph
pathogenesi
paradox
natur
vener
syphili
hamper
due
inabl
readili
propag
tp
vitro
well
lack
suitabl
inbr
anim
model
studi
diseas
nevertheless
much
learn
pathogenesi
vener
syphili
combin
analysi
epidemiolog
clinic
microbiolog
featur
variou
stage
diseas
current
studi
review
clinic
histopatholog
laboratori
featur
patient
diagnos
ss
network
public
sector
primari
health
care
provid
cali
colombia
concurr
determin
spirochet
dna
burden
wb
skin
sampl
subset
patient
use
highli
sensit
realtim
pcr
assay
conjunct
avail
cali
syphili
seropreval
data
studi
provid
clinic
microbiolog
evid
vener
syphili
highli
endem
region
colombia
find
also
make
evid
popul
earli
syphili
patient
may
go
undiagnos
untreat
sever
week
case
sever
month
also
provid
first
time
quantit
andor
qualit
molecular
evid
spirochet
present
signific
number
skin
blood
untreat
ss
patient
paradox
spirochet
persist
despit
known
presenc
circul
antitreponem
opson
antibodi
serum
ss
patient
well
robust
proinflammatori
dermal
cellular
immun
respons
characterist
stage
diseas
ss
patient
cali
colombia
recruit
part
ongo
syphili
immunolog
studi
cali
largest
citi
colombia
popul
mani
belong
middl
low
socioeconom
strata
respect
distinct
comuna
citi
consid
poor
less
adequ
access
health
care
servic
alreadi
allud
high
rpr
seroposit
rate
five
public
health
institut
call
empresa
social
del
estado
ese
strateg
locat
throughout
citi
respons
provid
region
health
care
local
popul
resid
variou
comuna
figur
prior
studi
initi
nurs
physician
work
decentr
hospit
health
care
center
affili
individu
ese
train
studi
personnel
properli
recogn
treat
earli
syphili
patient
patient
met
criteria
diagnosi
ss
agre
particip
studi
refer
particip
provid
centro
internacion
de
entrenamiento
e
investigacion
cideim
examin
studi
physician
confirmatori
blood
test
cideim
particip
requir
sign
inform
consent
studi
procedur
review
approv
human
subject
board
connecticut
children
medic
center
univers
connecticut
health
center
uchc
walter
reed
armi
institut
research
wrair
cideim
studi
protocol
also
review
ethic
committe
particip
ese
institut
review
board
center
diseas
control
prevent
cdc
approv
molecular
analysi
tp
dna
blood
sampl
skin
biopsi
obtain
secondari
syphili
patient
control
diagnosi
secondari
syphili
base
compat
medic
histori
appear
characterist
skin
mucos
lesion
see
reactiv
rpr
dilut
posit
confirmatori
treponem
test
fluoresc
treponem
antibodi
absorpt
ftaab
subject
complet
physic
examin
perform
one
two
train
dermatologist
ac
rt
well
vers
identif
vener
syphili
individu
case
histori
serolog
data
photograph
dermal
cutan
lesion
review
least
one
two
infecti
diseas
expert
jr
js
serolog
test
syphili
hiv
conduct
particip
central
refer
laboratori
cali
studi
subject
elig
particip
year
old
known
hiv
use
antibiot
within
week
prior
studi
entri
pregnant
women
also
exclud
particip
sociodemograph
characterist
relev
clinic
epidemiolog
inform
obtain
mean
standard
questionnair
studi
dermatologist
obtain
skin
biopsi
patient
repres
syphili
dermal
lesion
whole
blood
skin
biopsi
also
collect
subset
patient
real
time
polymeras
chain
reaction
pcr
tp
dna
quantit
see
patient
treat
million
unit
intramuscular
benzathin
penicillin
accord
colombian
public
health
guidelin
accord
avail
cdc
treatment
guidelin
patient
ask
return
within
day
followup
clinic
examin
repeat
rpr
titer
possibl
partner
notif
treatment
done
health
care
provid
citi
cali
health
depart
diagnosi
treatment
addit
std
done
patient
primari
health
care
provid
patient
non
treponem
rpr
treponem
ftaab
test
perform
refer
laboratori
colombia
eclia
electrochemiluminesc
immunoassay
hiv
serum
antibodi
test
complet
blood
count
cbc
manual
differenti
quantit
erythrocyt
sediment
rate
esr
also
done
women
underw
serum
pregnanc
test
none
posit
three
posit
hiv
eclia
identifi
studi
patient
subsequ
confirm
westernblot
analysi
hivposit
patient
refer
public
health
care
sector
hiv
clinic
addit
test
treatment
dark
field
microscopi
requir
studi
punch
biopsi
affect
dermal
site
obtain
studi
dermatologist
patient
deem
distinct
clinic
manifest
classic
associ
ss
avail
tissu
patient
stain
hematoxilineosin
h
e
warthinstarri
silver
stain
one
reveal
spirochet
silver
stain
individu
biopsi
sampl
systemat
analyz
train
pathologist
colombia
subsequ
corrobor
pathologist
unit
state
clinic
sensit
pola
realtim
pcr
determin
test
blood
spike
either
purifi
tp
dna
tp
organ
fifti
millilit
peripher
blood
collect
edta
tube
singl
donor
blood
sampl
maintain
room
temperatur
prior
perform
spike
experi
tp
grown
testi
new
zealand
white
rabbit
harvest
previous
describ
cultiv
pallidum
rabbit
approv
cdc
anim
care
committe
treponem
dilut
concentr
use
prewarm
tpcm
tp
cultiv
medium
tenfold
serial
dilut
suspens
perform
use
prewarm
tpcm
aliquot
tenfold
dilut
ad
duplic
ml
blood
one
set
tube
kept
room
temperatur
hr
second
set
place
refriger
hr
dna
extract
aliquot
dilut
tp
organ
tpcm
use
qiaamp
dna
mini
kit
qiagen
valencia
ca
purifi
dna
serial
dilut
tenfold
steril
pb
aliquot
tenfold
dilut
ad
duplic
ml
blood
tube
left
room
temperatur
hr
store
blood
spike
tp
organ
dna
extract
spike
blood
sampl
achiev
use
qiaamp
dna
midi
kit
qiagen
purifi
dna
elut
buffer
ae
sampl
test
duplic
use
realtim
pcr
target
dna
polymeras
gene
tp
pola
five
ten
millilit
whole
blood
collect
tube
contain
edta
edta
per
millilit
blood
ss
patient
enrol
last
three
year
studi
first
wb
sampl
collect
store
frozen
sever
day
subsequ
ship
dri
ice
overnight
uchc
dna
subsequ
extract
ml
whole
blood
use
qiaamp
dna
blood
mini
kit
qiagen
follow
procedur
recommend
manufactur
last
eleven
patient
enrol
studi
dna
extract
whole
blood
sampl
site
cideim
personnel
subsequ
ship
dri
ice
uchc
mmpunch
skin
biopsi
ss
lesion
also
obtain
group
patient
control
snapfrozen
store
liquid
nitrogen
prepar
overnight
transport
dri
ice
uchc
skin
three
healthi
control
also
obtain
cideim
handl
fashion
upon
arriv
uchc
dna
extract
skin
sampl
use
qiagen
dnaeasi
blood
tissu
kit
qiagen
dna
sampl
skin
wb
eventu
ship
dri
ice
laboratori
refer
research
branch
divis
std
prevent
cdc
atlanta
georgia
diagnost
pcr
test
sampl
test
use
realtim
pcr
target
tp
pola
gene
gene
bank
access
describ
pcr
amplif
perform
use
forward
primer
revers
primer
probe
previous
publish
except
probe
label
cyanin
end
blackhol
quencher
end
pcr
perform
reaction
volum
contain
follow
deoxynucleosid
triphosph
mix
datp
dctp
dgtp
dutp
mm
primer
uracil
nglycosylas
amplitaq
gold
polymeras
pcr
buffer
appli
biosystem
foster
citi
ca
probe
templat
dna
thermocycl
perform
rotorgen
instrument
qiagen
follow
min
min
cycl
sec
min
pcr
run
includ
posit
neg
templat
control
reaction
tp
copi
number
wb
specimen
extrapol
standard
curv
gener
use
tenfold
serial
dilut
purifi
tp
dna
human
ribonucleas
rnase
p
gene
pcr
assay
use
previous
describ
test
pcr
inhibit
blood
sampl
neg
pola
realtim
pcr
assay
strain
type
attempt
wb
skin
sampl
obtain
ss
patient
tpposit
diagnost
pcr
pcr
amplif
size
tandem
repeat
within
arp
acid
repeat
protein
gene
pcrrestrict
length
polymorph
rflp
analysi
tpr
pallidum
repeat
e
g
j
gene
done
previous
describ
pillay
et
al
two
modif
first
tandem
repeat
region
within
arp
gene
amplifi
new
primer
pair
use
exist
pcr
condit
arp
assay
second
pcr
amplicon
analyz
agil
bioanalyz
agil
technolog
san
diego
california
total
patient
age
year
median
year
met
case
definit
ss
recruit
network
primari
health
care
provid
locat
throughout
cali
figur
enrol
ss
patient
resid
comuna
citi
low
socioeconom
condit
particip
either
unschool
partial
complet
elementari
school
educ
directli
target
affluent
commun
cali
unabl
decis
conclud
ss
princip
affect
underprivileg
group
consist
prior
ss
case
seri
major
ss
patient
enrol
women
particip
either
afrocolombian
mix
race
mestizo
given
gener
popul
region
countri
afrocolombian
background
evid
studi
black
proportion
overrepres
major
subject
selfreport
highrisk
sexual
behavior
histori
includ
multipl
sexual
partner
rare
use
condom
andor
contact
commerci
sex
worker
almost
quarter
gave
histori
illicit
drug
use
state
consum
alcohol
routin
one
male
patient
admit
unprotect
sex
men
princip
risk
factor
acquir
syphili
subject
enrol
studi
newli
diagnos
hiv
diagnosi
hiv
coinfect
consist
avail
epidemiolog
biolog
evid
demonstr
infect
tp
increas
likelihood
transmit
acquir
hiv
mean
durat
sign
symptom
time
present
day
rang
median
durat
day
histori
undocu
fever
uncommon
howev
none
patient
enrol
febril
time
initi
physic
examin
mani
patient
report
mild
moder
flulik
symptom
dermal
mucos
find
accord
previous
describ
dermatolog
manifest
ss
tabl
typic
palmar
plantar
exanthem
ss
common
dermal
manifest
seen
figur
palmar
plantar
lesion
often
surround
hyperkeratosi
thin
white
ring
collar
scale
latter
classic
known
biett
collarett
agreement
chapel
mindel
classic
descript
ss
subject
also
faint
macular
papular
erupt
diffus
dissemin
trunk
upper
lower
extrem
figur
mani
case
dermal
lesion
hyperpig
figur
find
surprisingli
evid
darker
skin
individu
condyloma
lata
known
highli
infecti
present
patient
figur
one
subject
sever
larg
frambesiform
pustular
lesion
rare
manifest
diseas
plainli
evid
nasolabi
fold
lower
jaw
shown
three
patient
characterist
patchi
motheatenlik
alopecia
figur
resolv
penicillin
treatment
mucos
patch
genit
area
andor
oral
mucosa
also
commonli
seen
stage
diseas
observ
patient
figur
although
earli
dissemin
central
nervou
system
cn
known
occur
ss
patient
none
particip
overt
clinic
manifest
associ
mening
enceph
ie
meningismu
cranial
nerv
disord
visual
chang
intens
headach
major
patient
rpr
titer
third
titer
rpr
titer
followup
decreas
least
fourfold
patient
follow
day
hematolog
anomali
indic
system
inflammatori
natur
stage
diseas
norm
patient
studi
inde
half
patient
elev
erythrocyt
sediment
rate
esr
anem
sever
lymphopen
possibl
although
unlik
hematolog
chang
describ
herein
reflect
condit
might
present
underserv
individu
cali
tabl
summar
variou
histopatholog
anomali
seen
lesion
punch
biopsi
obtain
ss
patient
enrol
concert
prior
histolog
descript
ss
skin
biopsi
reveal
superfici
deep
dermal
cellular
infiltr
vari
intens
often
perivascular
distribut
primarili
compris
lymphocyt
plasma
cell
sever
histolog
pattern
involv
epidermi
also
seen
includ
area
focal
spongiosi
basal
vacuolar
chang
parakeratosi
epiderm
acanthosi
figur
depict
repres
histopatholog
abnorm
four
ss
patient
concert
known
low
sensit
warthinstarri
stain
detect
tp
tissu
spirochet
seen
one
biopsi
studi
previous
determin
wb
best
sampl
detect
spirochet
blood
obtain
infect
rabbit
unpublish
observ
confirm
use
spike
human
blood
wb
better
serum
plasma
peripher
blood
mononuclear
cell
pbmc
detect
spirochet
studi
therefor
elect
use
wb
sampl
quantit
level
spirochetemia
untreat
ss
patient
use
realtim
qpcr
assay
target
pola
gene
first
establish
sensit
assay
spirochetesml
irrespect
whether
freshli
extract
tp
dna
live
whole
spirochet
use
spike
blood
sampl
tabl
pola
pcr
detect
limit
blood
sampl
immedi
refriger
upon
spike
kept
total
hr
prior
dna
extract
one
log
higher
sampl
kept
room
temperatur
hr
process
use
highli
sensit
pcr
method
amplifi
tp
dna
wb
sampl
obtain
ss
patient
tabl
pola
copi
number
patient
rang
copiesml
wb
well
cutoff
assay
pcr
inhibit
observ
dna
sampl
test
neg
tp
pola
target
import
note
abil
detect
tp
dna
ss
patient
sampl
greatli
improv
wb
dna
extract
within
hour
procur
sampl
inde
sampl
handl
fashion
detect
tp
dna
wherea
wb
sampl
posit
wb
collect
frozen
ship
uchc
subsequ
dna
extract
cdc
find
highlight
import
time
specimen
process
handl
show
subtl
differ
techniqu
greatli
alter
abil
amplifi
tp
dna
tp
dna
also
detect
qualit
realtim
pcr
skin
biopsi
studi
tabl
three
four
skin
biopsi
detect
tp
dna
rtpcr
obtain
hyperkeratot
plantar
plaqu
five
patient
tp
dna
present
blood
skin
one
patient
spirochetemia
neg
pcr
skin
two
patient
detect
dna
punch
biopsi
materi
neg
pcr
result
wb
none
wb
sampl
analyz
suffici
quantiti
tp
dna
satisfactorili
perform
molecular
strain
type
hand
six
eight
posit
skin
sampl
amen
type
combin
arp
repeat
size
tpr
e
g
j
rflp
pattern
identifi
four
differ
strain
type
two
one
respect
remain
strain
partial
typeabl
tpr
rflp
analysi
pattern
although
possibl
gener
result
due
small
sampl
size
data
suggest
high
strain
divers
reflect
pattern
seen
south
africa
syphili
known
highli
endem
estim
quarter
yearli
case
infecti
syphili
occur
latin
america
caribbean
syphili
rigor
notifi
often
recogn
health
care
provid
region
countryspecif
diseas
preval
incid
rate
like
underestim
true
magnitud
problem
exist
publish
studi
provid
evid
vener
syphili
highli
endem
also
import
sexual
transmit
diseas
tropic
region
america
instanc
syphili
shown
lead
caus
genit
ulcer
diseas
peru
dominican
republ
second
genit
herp
likewis
anoth
studi
peru
preval
vener
syphili
estim
amongst
msm
social
margin
men
women
brazilian
studi
high
syphili
preval
rate
norm
prison
commerci
sex
worker
msm
high
syphili
preval
rate
also
document
msm
femal
sex
worker
hondura
guatemala
respect
sourc
paho
web
site
http
newpahoorg
access
juli
one
avail
studi
describ
epidemiolog
vener
syphili
colombia
femal
sex
worker
bogota
serolog
clinic
evid
diseas
although
current
studi
design
comprehens
epidemiolog
microbiolog
investig
syphili
cali
combin
observ
provid
evid
vener
syphili
highli
endem
region
colombia
assert
substanti
high
syphili
seropreval
rate
document
year
old
sexual
activ
men
women
poor
cali
district
find
also
make
evid
earli
syphili
patient
cali
may
go
undiagnos
untreat
sever
week
case
sever
month
surpris
given
clinic
manifest
ss
often
subtl
easili
overlook
andor
dismiss
primari
care
provid
patient
alik
princip
object
current
case
seri
thu
review
health
care
provid
particularli
practic
medicin
tropic
region
like
colombia
typic
clinic
manifest
associ
ss
although
larg
proport
patient
present
classic
palmoplantar
exanthem
ss
faint
hypo
hyperpig
macul
papul
could
easili
dismiss
dermatolog
condit
inde
rash
ss
may
frequent
confus
skin
disord
includ
pityriasi
rosea
psoriasi
seborrh
dermat
dermatomycosi
amongst
other
given
rel
high
preval
vener
syphili
popul
unreason
suggest
diagnosi
ss
consid
sexual
activ
individu
present
form
unexplain
skin
mucou
membran
patholog
perhap
even
individu
otherwis
unexplain
constitut
flulik
symptom
sever
investig
previous
use
molecular
method
detect
tp
dna
wb
tissu
untreat
earli
syphili
patient
studi
first
measur
spirochet
load
real
time
qpcr
blood
untreat
ss
patient
abil
detect
spirochet
dna
sampl
quit
variabl
highli
depend
variou
factor
includ
type
sampl
collect
stage
diseas
primari
vs
secondari
vs
latent
gene
target
use
nevertheless
readili
appar
signific
proport
earli
syphili
patient
regardless
stage
diseas
circul
spirochet
dna
current
studi
detect
limit
blood
sampl
spike
either
dna
whole
tp
organ
kept
hr
pola
copiesml
blood
compar
pola
copiesml
dilut
store
room
temperatur
hr
frozen
blood
sampl
store
sever
day
may
conduc
diagnost
pcr
test
spike
experi
indic
blood
sampl
store
hour
without
significantli
affect
capac
detect
tp
dna
may
prove
particularli
use
set
blood
sampl
process
day
collect
pcr
inhibit
observ
use
blood
spike
experi
despit
inher
high
concentr
human
dna
sampl
possibl
sever
ss
patient
enrol
spirochetem
detect
qpcr
may
due
patient
spirochetemia
threshold
assay
altern
treponem
dna
might
degrad
result
extract
within
hour
blood
collect
futur
studi
abil
detect
low
copi
number
may
enhanc
extract
dna
site
use
larger
volum
blood
vs
studi
also
perform
tp
strain
type
analysi
dna
materi
obtain
skin
sever
ss
patient
use
method
describ
pillay
provid
evid
citi
cali
consider
heterogen
circul
tp
strain
subtyp
known
worldwid
distribut
present
skin
two
ss
patient
subtyp
previous
identifi
syphili
patient
sever
citi
south
africa
also
present
skin
sampl
cali
strain
type
divers
cali
provid
addit
evid
vener
syphili
highli
endem
popul
much
larger
molecular
epidemiolog
studi
conduct
sever
south
african
citi
greater
geograph
tp
strain
divers
found
correl
statist
higher
syphili
preval
rate
content
improv
understand
heterogen
syphili
subtyp
help
identifi
introduct
new
strain
endem
popul
also
help
evalu
public
health
strategi
success
erad
indigen
strain
alreadi
allud
molecular
method
use
herein
provid
evid
signific
number
spirochet
present
skin
also
capabl
spread
signific
number
blood
stream
untreat
ss
patient
paradox
ss
patient
exhibit
robust
cellular
humor
adapt
immun
respons
care
analysi
tp
uniqu
ultrastructur
featur
provid
sever
explan
paradox
unlik
outer
membran
gramneg
bacteria
tp
lack
potent
proinflammatori
glycolipid
lipopolysaccharid
lp
addit
freezefractur
microscopi
studi
shown
spirochet
larg
devoid
integr
outermembran
protein
although
tp
contain
abund
highli
antigen
hydrophil
polypeptid
molecul
tether
coval
bound
ntermin
lipid
periplasm
leaflet
cytoplasm
membran
unusu
topolog
thought
contribut
abil
intact
spirochet
avoid
recognit
innat
immun
cell
ie
macrophag
pattern
recognit
receptor
prr
thu
delay
imped
activ
site
initi
inocul
skin
organ
spirochet
dissemin
ineffici
antibodi
bind
small
number
potenti
antigen
target
present
spirochet
outer
membran
could
also
allow
spirochet
shun
rapid
effici
bind
opson
antitreponem
antibodi
thu
avoid
phagocytosi
one
envis
model
pauciti
outer
membran
antigen
target
perhap
combin
slow
rate
bacteri
replic
facilit
intermitt
low
level
spread
spirochet
affect
skin
mucou
lesion
blood
stream
untreat
ss
patient
lastli
sequenc
variat
tp
repeat
tpr
famili
polymorph
multicopi
repeat
protein
postul
addit
mechan
immun
evas
persist
infect
spirochet
sever
protein
predict
outer
membran
locat
tprk
receiv
attent
although
controversi
remain
actual
locat
tprk
sequenc
divers
tprk
sampl
obtain
sever
syphili
patient
bolster
idea
molecul
could
play
import
role
immun
evas
sever
candid
outer
membran
protein
includ
current
studi
determin
meet
structur
featur
known
bacteri
outer
membran
protein
bind
syphilit
opson
antibodi
undergo
antigen
variat
conclud
high
syphili
preval
rate
region
prompt
health
care
worker
countri
like
colombia
maintain
high
index
suspicion
common
uncommon
manifest
earli
syphili
concert
clinic
find
highlight
herein
diagnosi
ss
must
consid
part
differenti
diagnosi
subject
present
chronic
skin
andor
mucos
lesion
public
health
care
author
must
redoubl
effort
enhanc
earli
detect
vener
syphili
institut
time
treatment
diseas
improv
followup
patient
diagnos
diseas
lastli
research
effort
design
better
understand
immunopathogenesi
diseas
particular
bacterium
abl
elud
host
immunolog
defens
spread
site
bacteri
replic
demonstr
herein
greatli
contribut
effect
novel
prevent
strategi
includ
develop
effect
vaccin
